Lorrie Kirshenbaum, PhD, chair of the Early Career Committee for Basic Cardiovascular Sciences (BCVS) 2015 Scientific Sessions, talks with Johannes Backs, one of the finalists for the 2015 BCVS Outstanding Early Career Award about his study, "Disrupting the Interaction Between CaM Kinase II and Histone Deacetylase 4--an Epigenetic Therapy for Heart Failure."
Lorrie Kirshenbaum, PhD, talks with Prabhakara R. Nagareddy, PhD, BCVS 2015 Outstanding Early Career Award Finalist, about his study, "Myelopoiesis Following Myocardial Ischemia (MI) Involves Activation of the Nlrp3 Inflammasome by Neutrophil-derived S100a8/a9.
Ronglih Liao, PhD, and Mark Sussman, PhD, moderators of a session on Sources of New Myocytes in Diseased Hearts, discuss what the various successful approaches to myocyte generation suggest for the possibility of identifying the underlying mechanisms and the potential development new treatment options for patients.
Lorrie Kirshenbaum, PhD, talks with Kunhua Song, PhD, Outstanding Early Career Award Finalist for BCVS 2015 about his study, "High Efficiency Reprogramming of Fibroblasts into Cardiomyocytes Requires Suppression of Pro-fibrotic Signaling"
Glenn C. Rowe, PhD and Joseph Libonati, PhD, moderators of a scientific session on Exercise and Heart Failure at BCVS 2015 discuss the benefits of exercise in heart failure, some recent scientific approaches to understanding the underlying biological processes, and their potential use for developing new therapies for patients.
Mark Creager, MD, president of the American Heart Association, interviews BCVS 2015 program Co-Chairs Anthony Rosenzweig, MD, Åsa Gustafsson, PhD, and David Lefer, PhD about the highlights of the science they have chosen for the meeting in New Orleans and its potential to improve patient care.